Stryker, Zimmer, Smith+Nephew warn orthopaedic headwinds to last into Q4

Smith+Nephew, Stryker and Zimmer Biomet have rounded out the current earnings season with third-quarter results, revealing how the orthopaedics industry remains constrained by COVID-19, hospital staffing shortages and lower pricing in China.

Analysts expected orthopaedic companies to fall short of prior revenue forecasts, having heard intra-quarter commentary about the impact of the U.S. delta wave and other forces. Even so, the results managed to throw up some surprises, such as Stryker’s orthopaedic and spine sales falling short of Evercore ISI expectations but being offset by MedSurg growth, and provide an outlook for the fourth quarter that disappointed some observers.

None are forecasting a strong rebound in the fourth quarter. Having reported a 5.9% underlying drop in third-quarter orthopaedic sales, Smith+Nephew forecast a deceleration of its overall business in the fourth quarter, reflecting fewer selling days than in the comparable period of last year. Smith+Nephew expects to hit the bottom end of its 10% to 13% full-year sales growth guidance, pointing to a sharp slowdown after nine months in which the business grew 14%.

Zimmer and Stryker also downplayed the prospects of a rapid recovery in the fourth quarter. Stryker expects fourth quarter growth of its more deferrable businesses to be similar to the delta-hit third quarter. Zimmer cut the midpoint of its full-year sales guidance by 23%, reflecting the impact of a weak third quarter and the assumption that the headwinds will persist.

“Until we see a fundamental shift in these trends, we’re just going to assume that these pressure points aren’t going away, but will be with us into Q4 and possibly into early 2022,” Zimmer CEO Bryan Hanson told investors on the third-quarter results conference call.

| MedTech Dive

Image Credit: Nick Paul Taylor / MedTech Dive

READ MORE

About Peter Coffaro 510 Articles
Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.